Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.

Lupride Depot 3.75mg

Generic: Leuprolide Acetateby Sun Pharmaceutical Industries Ltd

Buy Lupride Depot 3.75mg (Leuprolide Acetate) online | SafeRxPills

Select pack size

1
Free shipping over $149
Free reshipment if lost
Discreet packaging
WHO-GMP certified
Secure checkout

Similar medicines

View all
Buy Cabanex 0.5mg (Cabergoline) online | SafeRxPills

Cabanex 0.5mg

$81.60View
Buy Caberlin 0.25mg (Cabergoline) online | SafeRxPills

Caberlin 0.25mg

$21.00View
Caberlin 0.5mg tablet pack

Caberlin 0.5mg

$42.00View
Buy Cabgolin 0.25mg (Cabergoline) online | SafeRxPills

Cabgolin 0.25mg

$21.00View

About Lupride Depot 3.75mg

Lupride Depot 3.75mg is a one-month depot injection of leuprolide acetate (also spelled leuprorelin), 3.75 mg, from Sun Pharma, sold in India as a single vial. Leuprolide is a gonadotropin-releasing hormone (GnRH) agonist: after a short rise in hormones, monthly injections switch off the ovaries' oestrogen production (or testosterone in men). At this strength it is used mainly for endometriosis and to shrink uterine fibroids before surgery. We sell it as 1 or 2 injections, from $94.00 an injection in the 2 pack.

Three points first. This is a clinic medicine, not a home medicine. The US label for the same strength (Lupron Depot 3.75 mg) says it "must be administered by a healthcare professional" as an injection into a muscle, once a month, and the Indian listings say it is given by a doctor or nurse (MrMed: "Do not self-administer"). We would not recommend ordering it for self-injection. Only order it if the doctor or clinic who will give the injection has agreed to give it from your supply. Second, treatment time is limited because it thins the bones: the US label allows 6 months for a first course and a total of 12 months only with daily norethindrone acetate add-back tablets, and the UK label limits endometriosis treatment to 6 months. Third, it can harm an unborn baby and is not a contraceptive, so you need a non-hormonal method such as condoms during treatment. This page sets out the doses and warnings from the current US and UK labels, listed at the end.

Lupride Depot 3.75mg at a glance

Active ingredientLeuprolide acetate 3.75 mg, depot (slow release) powder for injection, one vial (Truemeds, PharmEasy, MediBuddy, GNH India)
Brand and makerLupride Depot, Sun Pharma. PharmEasy names Sun Pharmaceutical Industries Ltd (Halol, Gujarat); MediBuddy gives a Sun Pharmaceutical Industries Ltd address in East Sikkim; Truemeds names Sun Pharma Laboratories Ltd (Mumbai). Country of origin India
Who gives itA doctor or nurse. US label: "must be administered by a healthcare professional". MrMed: "Do not self-administer"; Truemeds: usually given by a healthcare professional
Regulatory statusLeuprolide 3.75 mg monthly depots are licensed in the US (Lupron Depot 3.75 mg), the UK (Prostap SR DCS 3.75 mg), Canada (Lupron Depot 3.75 mg) and Australia (Lucrin Depot 3.75 mg). This Indian Lupride Depot pack is not registered with the FDA, MHRA, TGA or Health Canada
Usual dose from the labels3.75 mg once a month. US: endometriosis up to 6 injections in a first course; fibroids up to 3. UK: endometriosis up to 6 months only; fibroids usually 3 to 4 months, at most 6; prostate cancer monthly, not stopped when the cancer improves
How long it lastsOne injection covers about a month: US label, blood levels stayed fairly stable for about four to five weeks; UK label, effective levels persist for 30 to 40 days
StorageBelow 25 C (Truemeds, MrMed, GNH India); MrMed adds "Do not refrigerate or freeze". Not a refrigerated product
Packs1 and 2 injections (one injection is one month)
Price per injection$114.00 (1 pack) or $94.00 (2 pack), before shipping
Delivery7 to 14 business days to the US, UK, Australia and Canada, without temperature control; $25 shipping under $149, free from $149

Price per injection

Prices below are as of October 2026; the pack selector shows the current price.

PackPricePer injectionShippingPer injection with shipping
1 injection$114$114.00$25$139.00
2 injections$188$94.00Free$94.00

The 2 pack is cheaper per injection before shipping as well, and it also clears the $149 free shipping line. In India, Truemeds, MrMed, PharmEasy and MediBuddy show an MRP of Rs 3,324.99 for one vial.

How many to buy. One injection is one month of treatment. A full first course for endometriosis under the US label is up to 6 injections, and a fibroid course up to 3. Our packs therefore cover one or two months, not a whole course. Buy only what the clinic giving the injections has agreed to use, check that the expiry date covers the planned injection dates (Truemeds lists expiry on or after February 2027; MediBuddy May 2028), and remember that each order takes 7 to 14 business days, so a monthly injection should not depend on a parcel arriving on time.

Compared with Lupron Depot, Prostap and US prices

Lupride Depot 3.75mg (ours, Indian pack)US Lupron Depot 3.75 mgUK Prostap SR DCS 3.75 mgCanada and Australia
Maker or licence holderSun Pharma (Indian listings)AbbVie (made by Takeda)Takeda UK LimitedCanada: Lupron Depot 3.75 mg, AbbVie Corporation. Australia: Lucrin Depot 3.75 mg
Registered with that country's regulatorNo: not registered with the FDA, MHRA, TGA or Health CanadaYes, FDA (NDA 020011), Rx onlyYes, MHRA (PL 16189/0012), prescription only medicineCanada: DIN 00884502, marketed, prescription. Australia: ARTG 337373
What is in the packOne vial (listings). Whether a diluent ampoule and syringe are included is not stated on the listings we checkedOne prefilled dual-chamber syringe (powder plus 1 mL diluent), plunger, two alcohol swabsOne dual-chamber prefilled syringe (powder plus 1 mL solvent), needle with safety device, plungerAustralia: prefilled dual-chamber syringe (ARTG entry)
Route in the labelInto a muscle or under the skin (Truemeds); MrMed says arm, thigh or abdomenIntramuscular onlyUnder the skin or into a muscleNot checked
Cost per injection$94.00 to $114.00 before shippingNADAC $1,820.83 per kit (effective 21 October 2026)Not checkedNot checked

NADAC is the average price US pharmacies pay to buy a medicine, published by the US Medicaid programme. In the NADAC file of 21 October 2026, Lupron Depot 3.75 mg kit (NDC 00074-3641-03) is $1,820.83250 per kit, effective 21 October 2026. We found no US generic 3.75 mg monthly depot in the FDA's NDC directory, and NADAC has no generic row for it; the US generic leuprolide rows in NADAC are a 14 mg/2.8 mL two-week kit (short-acting leuprolide), a different product. So per injection, ours costs far less than the US pharmacy acquisition cost of the brand. In our understanding, and not from a label, US patients usually get Lupron Depot through the clinic and their insurance, so what you would pay out of pocket depends on your plan. Ask the clinic before you order.

We have not seen any data comparing the release pattern of Lupride Depot with Lupron Depot or Prostap. A depot's effect depends on its slow-release formulation, not only on the 3.75 mg dose, and the US label warns that its own 1-month and 3-month depots are not interchangeable. Tell the clinic which brand you have.

Which strength to choose

The strength is chosen by the doctor from the schedule, not by the buyer. These are the Lupride products we list and the matching US labels.

ProductHow often in the matching labelUsed for (matching label)
Lupride Depot 3.75mg (this page)Once a monthUS Lupron Depot 3.75 mg: endometriosis; fibroids with anaemia, with iron. UK Prostap SR DCS 3.75 mg also covers prostate cancer, breast cancer and other uses
Lupride Depot 11.25mgOnce every 3 monthsUS Lupron Depot 11.25 mg: endometriosis (up to 2 injections in a first course); fibroids with anaemia, with iron
Lupride Depot 22.50mgOnce every 12 weeksUS Lupron Depot 22.5 mg: advanced prostate cancer

The US label is direct about not mixing depots: "Do not substitute LUPRON DEPOT 3.75 mg for LUPRON DEPOT 11.25 mg", "Do not administer LUPRON DEPOT 3.75 mg more frequently than once a month", and three 3.75 mg injections are "not equivalent" to one 11.25 mg injection (2.1). Never swap between strengths without the doctor treating you.

What it is used for, by label

  • US (Lupron Depot 3.75 mg). Management of endometriosis, "including pain relief and reduction of endometriotic lesions", alone or with norethindrone acetate add-back; and, with iron, "preoperative hematologic improvement of women with anemia caused by fibroids for whom three months of hormonal suppression is deemed necessary" (1.1, 1.2). The label suggests considering a one-month trial of iron alone first, as some women respond to iron alone. In the US, monthly leuprolide for advanced prostate cancer is a different strength, Lupron Depot 7.5 mg.
  • UK (Prostap SR DCS 3.75 mg). Prostate cancer (several settings); endometriosis; preparing the womb lining before surgery such as endometrial ablation; shrinking fibroids before surgery; protecting ovarian function during chemotherapy; breast cancer in pre- and perimenopausal women; and central precocious puberty in children (4.1).
  • Indian listings. Truemeds, PharmEasy and GNH India list prostate cancer, endometriosis and uterine fibroids, with central precocious puberty or assisted reproduction on some listings; MrMed also lists hormone-responsive breast cancer. We could not find Sun Pharma's own prescribing information for Lupride Depot, so these uses come from pharmacy listings, not the Indian label.

What the trials found

  • Endometriosis. In controlled studies, 3.75 mg monthly for six months was "comparable to danazol 800 mg/day" in relieving pain and other signs and in shrinking implants seen at laparoscopy. Periods stopped in 74% of women after the first month and 98% after the second; normal cycles returned in 7%, 71% and 95% in the first, second and third months after stopping (US 14.1).
  • Fibroids with anaemia. In one trial, 75% of women on 3.75 mg plus iron reached a haematocrit of 36% or more and haemoglobin of 12 g/dL or more at week 12, against 49% on iron alone (US Table 11). Across three other trials, uterine volume fell by a mean of 41% and fibroid volume by 37%; after stopping, the womb took a mean of 8.3 months to return to its pretreatment size (US 14.2).
  • Compared with dienogest tablets. In a 24 week trial of 252 women, pelvic pain fell by a similar amount on dienogest 2 mg daily (Visanne) and on leuprorelin 3.75 mg every 4 weeks: 47.5 mm and 46.0 mm on a 100 mm scale, per protocol (Canadian Visanne monograph; Strowitzki 2010). Bone density fell by a mean of 4.04% over 6 months in 29 women on leuprorelin, and did not fall in 21 women on dienogest (UK dienogest label 5.1).
Line chart of mean pelvic pain score over 24 weeks. Visanne 2 mg daily: 60.2 at start, 35.7, 24.2, 19.7, 16.2, 12.5 and 12.7 at weeks 4 to 24. Leuprorelin 3.75 mg every 4 weeks: 57.9, 32.6, 21.7, 18.7, 14.6, 12.8 and 11.9. Reductions 47.5 mm vs 46.0 mm; non-inferiority shown.
Pain over 24 weeks on Visanne tablets or leuprorelin 3.75 mg injections. Lumbar spine bone density changed +0.25% on dienogest and -4.04% on leuprorelin (P=0.0003). Source: Visanne Canadian product monograph, Table 8; Strowitzki 2010.

For many women a daily tablet such as Visanne is an option to discuss with a gynaecologist before a GnRH agonist injection. That is our suggestion, not a label statement.

How Lupride Depot 3.75mg is given

This section is for you and the professional giving the injection. It summarises the labels; it is not a guide to injecting yourself.

  1. Who and where. US: "must be administered by a healthcare professional" (2.1). The UK label is written for healthcare professionals and says the suspension must be prepared at the time of use and used immediately (4.4).
  2. Route. US Lupron Depot 3.75 mg is a single intramuscular injection into the buttock, front of the thigh or upper arm, with sites alternated (2.2). UK Prostap SR is given under the skin or into a muscle (4.2). Indian listings differ (Truemeds: into a muscle or under the skin; MrMed: arm, thigh or abdomen). Follow the clinic.
  3. Timing. Once a month, never more often (US 2.1). For endometriosis the UK label says to start during the first 5 days of the menstrual cycle (4.2).
  4. Mixing. The depot powder must be mixed with its diluent into a milky suspension just before injection. US: inject immediately or discard if not used within two hours, as there is no preservative; do not use if clumping or caking is present or powder has not gone into suspension (2.2). The US and UK products come as dual-chamber syringes. The Indian Lupride Depot listings show a vial, and we have not confirmed whether our stock includes a diluent ampoule and syringe. Ask us before you order, and show the carton to the clinic.
  5. Look at it. Inspect for particles and discolouration before use (US 2.2).
  6. Missed injections. The UK label warns that missing successive doses can lead to breakthrough bleeding or ovulation, with a chance of pregnancy (4.6).

Treatment limits and add-back therapy

  • US endometriosis course. First course: one injection a month for 1 to 6 months, with or without norethindrone acetate 5 mg daily. A second course: up to 6 more months, "but only with the addition of norethindrone acetate add-back therapy. Do not re-treat with LUPRON DEPOT 3.75 mg alone." Bone density should be assessed before retreatment, and the total "should not exceed 12 months due to concerns about adverse impact on bone mineral density" (US 1.1, 2.1).
  • US fibroids. One injection a month for up to three months, with iron; the label says it is not indicated with norethindrone add-back for this use (1.2, 2.1).
  • UK. Endometriosis "up to 6 months only"; HRT (an oestrogen and a progestogen) may be added to reduce bone loss and hot flushes. Fibroids usually 3 to 4 months, at most six. If treatment must be resumed, bone changes should be closely followed (4.2, 4.4).
  • Bone numbers. In the US add-back study, spine bone density fell by a mean of 6.3% after a year on 3.75 mg alone, against 1.0% with norethindrone add-back; 12 months after stopping, the leuprolide-only group was still 2.2% below baseline (US Tables 9 and 10). The US label says some bone loss "may not be reversible after stopping treatment" (5.1). The UK label says the generally accepted level of bone loss with GnRH analogues such as Prostap SR is 5%, and its studies found 2.3% to 15.7% depending on how it was measured (4.4).

Norethindrone acetate is called norethisterone in the UK and India. Add-back tablets are a prescription decision for your doctor; do not start them on your own.

Extra care for some groups

  • Bone risk factors. Heavy alcohol use (US: more than 3 units a day), smoking, a strong family history of osteoporosis, or long-term anticonvulsants or corticosteroids: the US label says leuprolide "may pose an additional risk" and the risks and benefits should be weighed carefully (5.1). UK: before fibroid treatment, women with major risk factors should have a bone scan, and treatment should not start if results are below the normal range (4.4).
  • Depression. Depression "may occur or worsen"; women with a history of depression should be carefully observed (US 5.7). UK: increased risk of depression, which may be severe, and rare reports of suicidal thoughts (4.4).
  • Seizures. Convulsions have been reported after marketing, in women with and without other medicines or conditions (US 5.6; UK 4.4).
  • Asthma and allergies. In US trials, asthma events were reported in women with a history of asthma, sinusitis or drug or environmental allergies (5.4).
  • Diabetes and heart risk. The UK label says GnRH agonists may reduce glucose tolerance or worsen diabetes and may raise cardiovascular risk; diabetic patients may need more frequent blood glucose checks (4.4).
  • Submucous fibroids. The UK label reports severe vaginal bleeding after injection from acute degeneration of fibroids (4.4).
  • Men with prostate cancer. Testosterone rises in the first weeks ("tumour flare"), which can worsen bone pain, urinary blockage or spinal cord compression; the UK label says an anti-androgen may be started 3 days before (4.4). Both the UK label and the US Lupron Depot prostate label warn that androgen deprivation therapy may prolong the QT interval, so heart rhythm risks and QT-prolonging medicines should be assessed (UK 4.4, 4.5; US prostate label 5.4).
  • After menopause. US: "not indicated in postmenopausal women and has not been studied in this population" (8.5).
  • Other medicines. No drug interaction studies have been done; leuprolide is a peptide not broken down by cytochrome P450 enzymes (US 7, 12.3).
  • Driving. The UK label says it can affect driving because of visual disturbances and dizziness (4.7).

Side effects

Most side effects come from the low oestrogen state. This table shows selected rows from the US label's table of two endometriosis studies (Table 2); the full table is longer.

Side effectLupron Depot 3.75 mg (166 women)Danazol (136)Placebo (31)
Hot flashes or sweats84%57%29%
Headache32%22%6%
Vaginitis (vaginal dryness or irritation)28%17%0%
Depression or emotional lability22%20%3%
General pain19%16%3%
Weight gain or loss13%26%0%
Nausea or vomiting13%13%3%
Decreased libido11%4%0%
Dizziness11%3%0%
Acne10%20%0%

Selected rows. Source: Lupron Depot 3.75 mg US prescribing information, Table 2.

With norethindrone add-back, hot flashes were less common (87% against 98% on leuprolide alone over 6 months in the controlled study, US Table 4). Other effects in the label: rises in cholesterol and triglycerides (6.1), liver enzyme rises (6.1), injection site reactions including abscess and necrosis, serious liver injury, and blood clots, heart attack and stroke reported after marketing (6.2). The UK label also lists idiopathic intracranial hypertension (raised pressure in the skull) and fatty liver (4.4). Normal hormone function usually returns within three months after the last injection (US 12.2).

When to get urgent help

Get emergency help straight away, or tell the clinic staff at once if you are still there, if any of these happen:

  • Swelling of the lips, tongue, face or throat, hives, wheezing or trouble breathing (hypersensitivity reactions, including anaphylaxis, US 5.4).
  • Fever or flu-like symptoms with a spreading rash, blisters, peeling skin or mouth sores (severe skin reactions such as SJS/TEN or DRESS; the US label says stop and contact your healthcare provider immediately, 5.3, 17).
  • A sudden severe headache, vomiting, vision changes or confusion, especially in the first 2 weeks (pituitary apoplexy, reported mostly in people with a pituitary tumour; US 6.2 says immediate medical attention has been required).
  • A seizure (US 17: seek medical attention).
  • Thoughts of suicide or self-harm, or depression that is getting worse (US 17: report immediately).
  • Chest pain, sudden breathlessness, a painful swollen leg, or signs of a stroke such as weakness on one side or trouble speaking.
  • Very heavy vaginal bleeding or severe pelvic pain, especially with fibroids (UK 4.4).
  • In men: new back pain with leg weakness or numbness, or being unable to pass urine (flare, UK 4.4).

The order of this list and "straight away" are our general safety advice. Tell the emergency staff that you are on leuprolide (Lupride Depot), the dose, and the date of your last injection. If you think you may be pregnant, tell your doctor at once (US 5.2).

Who should not use Lupride Depot 3.75mg

Contraindicated (never use it if):

  • you are allergic to GnRH, GnRH agonists including leuprolide, or any ingredient of the product (US 4; UK 4.3).
  • you are pregnant (US 4), or are or may become pregnant while receiving it (UK 4.3). The US label says it "may cause fetal harm"; the UK label reports foetal malformation when it was given during pregnancy (4.6).
  • you have undiagnosed abnormal uterine bleeding (US 4). The UK label says it "should not be used" in women with undiagnosed abnormal vaginal bleeding (4.3).
  • it would be given with norethindrone acetate add-back and you have a reason not to take norethindrone: the US label says norethindrone's contraindications then also apply (4).
  • for breast cancer: an aromatase inhibitor would be started before the ovaries are adequately suppressed (UK 4.3).

Should not be used, or only after careful assessment:

  • Breastfeeding: the UK label says it "should not be used in women who are breastfeeding" and "must not be used" in pregnant or breastfeeding women (4.3, 4.6). The US label says there are no data and the benefits and risks should be weighed (8.2).
  • Contraception: it is "not a contraceptive" (US 8.3). Both labels say to use non-hormonal contraception during treatment; the UK label adds until periods return after stopping (US 5.2; UK 4.6).
  • Fibroids not confirmed: the UK label says the fibroid diagnosis must be confirmed and an ovarian mass excluded before treatment (4.4).
  • Low bone density or major bone risk factors: see Extra care above.
  • Girls before their first period: safety and effectiveness of the 3.75 mg monthly depot for endometriosis and fibroids are not established (US 8.4). Children with early puberty are treated under a paediatric endocrinologist (UK 4.2).

Storage

  • Temperature. Truemeds and GNH India list Lupride Depot 3.75 mg as store below 25 C; MrMed says store below 25 C, "Do not refrigerate or freeze". The US Lupron Depot 3.75 mg label says store at 20 to 25 C with excursions permitted to 15 to 30 C; the UK Prostap SR label says do not store above 25 C, do not refrigerate or freeze, and protect from light (6.4). It does not need a fridge.
  • After mixing. Use immediately (UK) or within two hours (US). Mixing is done by the clinic.
  • Heat in transit. Our parcels travel for 7 to 14 business days without temperature control and can be exposed to more than 25 C in summer. Keep the pack in its carton, away from light and heat, when it arrives, and let the clinic inspect it before use. That is our advice.

Prescription and legal status

In the US, Lupron Depot is a prescription medicine ("Rx only"), and the FDA says personal importation of unapproved medicines is illegal in most circumstances. In the UK, Prostap SR DCS 3.75 mg is a prescription only medicine. In Canada, Lupron Depot 3.75 mg is a marketed prescription product. In Australia, Lucrin Depot 3.75 mg is on the TGA register (ARTG 337373), and healthdirect lists Lucrin Depot as Schedule 4, prescription only. In India, Truemeds, MrMed and MediBuddy mark Lupride Depot 3.75 mg as prescription required. Whatever the rules where you live, the labels say it is given by a healthcare professional. Check the rules where you live.

Buying genuine Lupride Depot

The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have", and it advises UK buyers to "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning covers this Indian Lupride Depot pack. When your order arrives, check that the carton and vial say Lupride Depot, leuprolide acetate and 3.75 mg, with Sun Pharma, a batch number and an expiry date, and that the seal is intact. These checks cannot prove that an injection is genuine or sterile, because counterfeiters copy packaging. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.

Delivery

We ship Lupride Depot 3.75mg to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.

Related guides

Sources

  • LUPRON DEPOT 3.75 mg (leuprolide acetate for depot suspension), US prescribing information, AbbVie Inc., DailyMed setid 00c486b0-bd7b-4898-834d-8c656e5e73cb, SPL version 1478, effective 18 September 2025 (revised 09/2025): sections 1, 2, 4, 5, 6, 7, 8, 12, 14, 16, 17. DailyMed
  • LUPRON DEPOT 11.25 mg US prescribing information, AbbVie Inc., DailyMed setid 60aad237-e1da-4705-cbbb-b3ca79e89ad8, effective 10 September 2025: sections 1, 2.1. DailyMed
  • LUPRON DEPOT 7.5 mg, 22.5 mg, 30 mg and 45 mg (prostate cancer), US prescribing information, AbbVie Inc., DailyMed setid cbc8f94e-7330-4465-05ad-16d64493a5dd, effective 15 March 2026: sections 1, 2, 5. DailyMed
  • Prostap SR DCS 3.75 mg, UK SmPC, Takeda UK Limited, PL 16189/0012, text revised 15/10/2026: sections 2, 4.1 to 4.9, 5.1, 5.2, 6.4, 6.5. emc
  • Health Canada Drug Product Database: Lupron Depot 3.75 mg, DIN 00884502, AbbVie Corporation, marketed, prescription; searched 26 October 2026. Health Canada
  • TGA, Australian Register of Therapeutic Goods: Lucrin Depot leuprorelin acetate 3.75 mg prefilled dual-chamber syringe, ARTG 337373; healthdirect, Lucrin Depot, Schedule 4; checked 26 October 2026. TGA
  • Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC) 2026, file of 21 October 2026: Lupron Depot 3.75 mg kit, NDC 00074364103, $1,820.83250 per kit, effective 21 October 2026. data.medicaid.gov
  • US Food and Drug Administration, openFDA NDC directory: Lupron Depot NDA 020011; searched 26 October 2026.
  • Dienogest 2 mg (Dimetrum) UK SmPC section 5.1, and Visanne Canadian product monograph, Table 8 (Study 97085). Strowitzki T, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis. Hum Reprod 2010. PMID 20089522.
  • Indian listings for Lupride Depot 3.75 mg (Truemeds, PharmEasy, MrMed, MediBuddy, GNH India), checked 26 October 2026.
  • MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
  • US Food and Drug Administration. Personal Importation. FDA

This page is for information and is not medical advice. Lupride Depot 3.75mg is a prescription injection that must be given by a healthcare professional. It is not for self-injection at home.

Frequently asked questions

What is Lupride Depot 3.75mg?

Lupride Depot 3.75mg is a one-month depot injection of leuprolide acetate (leuprorelin) 3.75 mg from Sun Pharma, sold in India as one vial. Leuprolide is a GnRH agonist that, after a short rise in hormones, switches off oestrogen production by the ovaries (or testosterone in men). At this strength it is used mainly for endometriosis and to shrink fibroids before surgery; the UK 3.75 mg label also covers prostate cancer and some breast cancers.

Is it the same as Lupron Depot 3.75 mg or Prostap SR?

The active ingredient and dose are the same, but this Indian pack is not registered with the FDA, MHRA, TGA or Health Canada, and we have not seen data comparing its slow-release formulation with Lupron Depot or Prostap. The US and UK products come as dual-chamber prefilled syringes; the Indian listings show a vial, and we have not confirmed whether a diluent and syringe are included. Ask us before ordering and show the carton to the clinic.

What does Lupride Depot 3.75mg cost per injection?

As of October 2026, $114 for 1 injection and $188 for 2 injections ($94.00 each), before shipping. Shipping is $25 on orders under $149 and free from $149, so the cost with shipping is $139.00 or $94.00 an injection. The pack selector shows the current price. For comparison, the US NADAC rate for a Lupron Depot 3.75 mg kit is $1,820.83 (effective 21 October 2026); what a US patient pays depends on the clinic and insurance.

Can I inject Lupride Depot myself at home?

We would not recommend it, and we would not recommend ordering it for self-injection. The US label for the same strength says it must be administered by a healthcare professional, as an injection into a muscle, and MrMed's Indian listing says do not self-administer. The powder must be mixed into a suspension and injected straight away. Only order it if the doctor or clinic who will give the injection has agreed to use your supply.

How often is it given and for how long?

Once a month, never more often (US label). For endometriosis the US label allows a first course of up to 6 injections, with or without norethindrone acetate 5 mg daily, and a second course of up to 6 more only with norethindrone add-back, to a total of no more than 12 months because of bone loss. The UK label limits endometriosis treatment to 6 months. For fibroids the US label allows up to 3 months with iron; the UK label usually 3 to 4 months and at most 6.

Which Lupride strength do I need?

Your doctor decides from the schedule. Lupride Depot 3.75mg matches the US one-month 3.75 mg depot. Lupride Depot 11.25mg matches the three-month depot for endometriosis and fibroids, and Lupride Depot 22.50mg matches the 12-week prostate cancer depot. The US label says not to substitute the 3.75 mg depot for the 11.25 mg depot and that three 3.75 mg injections are not equivalent to one 11.25 mg injection.

Does it thin the bones?

Yes. The US label says it causes bone mineral density loss, some of which may not be reversible. In a US study, spine bone density fell by a mean of 6.3% after a year on 3.75 mg alone and 1.0% with norethindrone add-back. The UK label says the generally accepted level of bone loss with GnRH analogues is 5%. That is why treatment time is limited and why add-back therapy is used for longer courses.

What are the common side effects?

In two US endometriosis studies, hot flashes or sweats affected 84% of women on Lupron Depot 3.75 mg (29% on placebo), headache 32%, vaginitis 28%, depression or mood swings 22%, and decreased libido 11%. Symptoms can get worse in the first days after the first injection before they settle (US 5.5). Serious effects reported in the labels include allergic reactions, severe skin reactions, seizures, worsening depression and, mostly in people with a pituitary tumour, pituitary apoplexy.

Who should not use Lupride Depot 3.75mg?

The US label says never use it if you are pregnant, are allergic to leuprolide or other GnRH drugs, or have undiagnosed abnormal uterine bleeding. The UK label says it must not be used in women who are or may become pregnant while receiving it, and should not be used while breastfeeding or with undiagnosed abnormal vaginal bleeding. It is not a contraceptive: both labels say to use a non-hormonal method such as condoms during treatment, and the UK label adds until periods return. The US label says it is not indicated after the menopause.

Do I need a prescription?

Yes, in practice. Lupron Depot is prescription only in the US, Prostap SR is a prescription only medicine in the UK, Lupron Depot 3.75 mg is a prescription product in Canada, and healthdirect lists Lucrin Depot as Schedule 4 in Australia. Indian pharmacies (Truemeds, MrMed, MediBuddy) mark Lupride Depot as prescription required. The FDA says personal importation of unapproved medicines is illegal in most circumstances.

How is it stored and how long does delivery take?

Indian listings say store below 25 C, and MrMed adds do not refrigerate or freeze; it is not a fridge product. Delivery to the US, UK, Australia and Canada takes 7 to 14 business days in plain, tracked packaging without temperature control, so keep it in its carton away from heat when it arrives and let the clinic inspect it. Shipping is $25 under $149 and free from $149. Because each order takes up to 14 business days, plan monthly injections well ahead.

Guide to Female Infertility & Ovulation InductionHow clomiphene triggers ovulation in PCOS and anovulatory women, success rates, dosing protocol, how to time sex around Clomid, and what to do if it does not work.

Related articles

Customer Reviews

No reviews yet. Bought Lupride Depot 3.75mg? Tell other buyers how it went.